ALUR
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.46 | $3M | -$3M |
| 2025 Q4 | -0.49 | $4M | -$5M |
| 2025 Q3 | -1.53 | $3M | -$7M |
| 2025 Q2 | -1.28 | $3M | -$8M |
| 2025 Q1 | -0.31 | $6M | -$9M |
| 2024 Q4 | -7.94 | $6M | -$13M |
| 2024 Q3 | -3.51 | $5M | -$12M |
| 2024 Q2 | -4.34 | $12M | -$9M |